Poly(D,L-lactide-co-glycolide) protein-loaded nanoparticles prepared by the double emulsion method-processing and formulation issues for enhanced entrapment efficiency

被引:114
作者
Bilati, U
Allémann, E
Doelker, E
机构
[1] Univ Geneva, Ecole Pharm Geneve Lausanne, Sch Pharmaceut Sci, CH-1211 Geneva, Switzerland
[2] Bracco Res SA, Geneva, Switzerland
关键词
albumin; double emulsion; entrapment efficiency; nanoparticles; poly(D; L-lactide-co-glycolide); process; parameters; proteins;
D O I
10.1080/02652040400026442
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
Although extensive research in the field of biodegradable microparticles containing peptide or protein drugs has greatly advanced production know-how, the effects of critical parameters influencing successful drug entrapment have not yet been sufficiently investigated with nano-scaled carriers. This paper deals with the formulation and processing parameters of the w(1)/o/w(2) double emulsion method that can affect nanoparticle size and loading. Fluorescein isothiocyanate-labelled bovine serum albumin (FITC-BSA) was used as a model protein. Results showed that high FITC-BSA entrapment efficiencies were reached (> 80%) when sonication was used for the two emulsification steps of the nanoparticle formation, independently of the mixing durations and intensities. By comparison, the use of a vortex mixer for obtaining the primary w(1)/o emulsion led to a rather poor entrapment efficiency ( similar to 25%). Some inherent properties of the poly( D, L-lactic-co-glycolic acid) polymer, such as, for example, high molecular weight, high hydrophilicity or the presence of free carboxylic end groups, enhanced the drug entrapment efficiency. It was also demonstrated that a low nominal drug loading, a large volume of the inner w(1) phase or the choice of methylene chloride instead of ethyl acetate as organic solvent favoured the drug entrapment, with entrapment efficiency values often reaching 100%. However, when using methylene chloride, the mean particle size was substantially increased, due to the presence of larger particles. Mean particle size increased also when the polymer concentration in the organic phase was increased.
引用
收藏
页码:205 / 214
页数:10
相关论文
共 24 条
[1]   ENCAPSULATION OF WATER-SOLUBLE DRUGS BY A MODIFIED SOLVENT EVAPORATION METHOD .1. EFFECT OF PROCESS AND FORMULATION VARIABLES ON DRUG ENTRAPMENT [J].
ALEX, R ;
BODMEIER, R .
JOURNAL OF MICROENCAPSULATION, 1990, 7 (03) :347-355
[2]   The incorporation and release of bovine serum albumin from poly-hydroxybutyrate-hydroxyvalerate microcapsules [J].
Atkins, TW ;
Peacock, SJ .
JOURNAL OF MICROENCAPSULATION, 1996, 13 (06) :709-717
[3]   Sonication parameters for the preparation of biodegradable nanocapsules of controlled size by the double emulsion method [J].
Bilati, U ;
Allémann, E ;
Doelker, E .
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2003, 8 (01) :1-9
[4]   Influence of the preparation method on residual solvents in biodegradable microspheres [J].
Bitz, C ;
Doelker, E .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1996, 131 (02) :171-181
[5]   Protein encapsulation and release from poly(lactide-co-glycolide) microspheres: effect of the protein and polymer properties and of the co-encapsulation of surfactants [J].
Blanco, D ;
Alonso, MJ .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 1998, 45 (03) :285-294
[6]   Development and characterization of protein-loaded poly(lactide-co-glycolide) nanospheres [J].
Blanco, MD ;
Alonso, MJ .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 1997, 43 (03) :287-294
[7]   THE PREPARATION AND EVALUATION OF DRUG-CONTAINING POLY(DL-LACTIDE) MICROSPHERES FORMED BY THE SOLVENT EVAPORATION METHOD [J].
BODMEIER, R ;
MCGINITY, JW .
PHARMACEUTICAL RESEARCH, 1987, 4 (06) :465-471
[8]  
Conway BR, 1996, EUR J PHARM BIOPHARM, V42, P42
[9]   Ketoprofen-poly(D,L-lactic-co-glycolic acid) microspheres: influence of manufacturing parameters and type of polymer on the release characteristics [J].
Gabor, F ;
Ertl, B ;
Wirth, M ;
Mallinger, R .
JOURNAL OF MICROENCAPSULATION, 1999, 16 (01) :1-12
[10]  
Gaspar MM, 1998, J CONTROL RELEASE, V52, P53